AAAAAA

   
Results: 1-19 |
Results: 19

Authors: ROLSTON DDK RUBIN S TOPOLSKY D STYLER M CRILLEY P
Citation: Ddk. Rolston et al., ARTERIAL OCCLUSIONS AS A PRESENTING FEATURE OF ACUTE PROMYELOCYTIC LEUKEMIA, American journal of clinical oncology, 21(5), 1998, pp. 436-437

Authors: LINKER CA RIES CA DAMON LE RUGO HS WOLF JL TOPOLSKY D CRILLEY P BRODSKY I RUBIN A CASE D ZAMKOFF K
Citation: Ca. Linker et al., AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR ACUTE MYELOID-LEUKEMIA IN FIRST REMISSION, Blood, 90(10), 1997, pp. 493-493

Authors: CRILLEY P TOPOLSKY D MARKS DI STYLER M SABOL P BRODSKY I
Citation: P. Crilley et al., LOW INCIDENCE OF FUNGAL-INFECTIONS IN PATIENTS UNDERGOING UNRELATED DONOR BONE-MARROW TRANSPLANTS FOLLOWED BY GM-CSF, Experimental hematology, 24(9), 1996, pp. 633-633

Authors: COPELAN EA BIGGS JC SZER J CRILLEY P ATKINSON K AVALOS B TOPOLSKY D PENZA SL ELDER PJ BULOVA SL BRODSKY I
Citation: Ea. Copelan et al., TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA (CML) WITH ALLOGENEIC BONE-MARROW TRANSPLANTATION AFTER PREPARATION WITH BUCY2, Experimental hematology, 24(9), 1996, pp. 670-670

Authors: STYLER MJ CRILLEY P BIGGS J MOUL J COPELAN E TOPOLSKY D AVALOS B PENZA S SABOL P DOWNS K SZER J BRODSKY I MARKS DI
Citation: Mj. Styler et al., HEPATIC-DYSFUNCTION FOLLOWING BUSULFAN AND CYCLOPHOSPHAMIDE MYELOABLATION - A RETROSPECTIVE, MULTICENTER ANALYSIS, Bone marrow transplantation, 18(1), 1996, pp. 171-176

Authors: TOPOLSKY D CRILLEY P STYLER MJ BULOVA S BRODSKY I MARKS DI
Citation: D. Topolsky et al., UNRELATED DONOR BONE-MARROW TRANSPLANTATION WITHOUT T-CELL DEPLETION USING A CHEMOTHERAPY ONLY CONDITIONING REGIMEN - LOW INCIDENCE OF FAILED ENGRAFTMENT AND SEVERE ACUTE GVHD, Bone marrow transplantation, 17(4), 1996, pp. 549-554

Authors: STYLER M CRILLEY P TOPOLSKY D RUBIN S SABOL P KING R BRODSKY I
Citation: M. Styler et al., LOW-MOLECULAR-WEIGHT HEPARIN-PROPHYLAXIS FOR VENOOCCLUSIVE DISEASE INUNRELATED MARROW TRANSPLANT RECIPIENTS, Blood, 88(10), 1996, pp. 3765-3765

Authors: TOPOLSKY D KING R MULLANEY R STYLER M CRILLEY P SABOL P BRODSKY L
Citation: D. Topolsky et al., THE USE OF G-CSF AFTER PERIPHERAL STEM-CELL (PBSC) TRANSPLANT - BEGINNING AT DIFFERENT INTERVALS POST INFUSION, Blood, 88(10), 1996, pp. 3766-3766

Authors: CRILLEY P TOPOLSKY D STYLER MJ BERNSTEIN E RESNICK K MULLANEY R BULOVA S BRODSKY I MARKS DI
Citation: P. Crilley et al., EXTRAMEDULLARY TOXICITY OF A CONDITIONING REGIMEN CONTAINING BUSULFAN, CYCLOPHOSPHAMIDE AND ETOPOSIDE IN 84 PATIENTS UNDERGOING AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 15(3), 1995, pp. 361-365

Authors: TOPOLSKY D BIGGS D
Citation: D. Topolsky et D. Biggs, TRANSPLANTATION IN MULTIPLE-MYELOMA, Seminars in oncology, 22(3), 1995, pp. 230-237

Authors: LINKER CA RIES CA DAMON LE RUGO HS TOPOLSKY D CRILLEY P BRODSKY I RUBIN A CASE D
Citation: Ca. Linker et al., AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR ACUTE MYELOID-LEUKEMIA IN FIRST REMISSION, Blood, 86(10), 1995, pp. 384-384

Authors: TOPOLSKY D BLUMBERG E CRILLEY P STYLER M HAYDEN F CHURCHILL K MORRIS M BRODSKY I
Citation: D. Topolsky et al., EFFECT OF INFLUENZA VACCINE POST-ALLOGENEIC BONE-MARROW TRANSPLANT, Blood, 86(10), 1995, pp. 860-860

Authors: HEFFLER KF GROSSMAN H MARKS D TOPOLSKY D STYLER M MOUL J CRILLEY P BRODSKY I
Citation: Kf. Heffler et al., OCULAR GRAFT-VERSUS-HOST DISEASE, Blood, 86(10), 1995, pp. 3784-3784

Authors: MARKS DI TOPOLSKY D CRILLEY P STYLER MJ BULOVA S BRODSKY I
Citation: Di. Marks et al., UNRELATED DONOR BONE-MARROW TRANSPLANTATION IN OLDER PATIENTS, Blood, 86(10), 1995, pp. 3813-3813

Authors: MARKS D CRILLEY P STYLER M TOPOLSKY D MANALO Y BRODSKY I
Citation: D. Marks et al., BUCY3 CONDITIONING FOR UNRELATED DONOR TRANSPLANTS FOR HEMATOLOGIC MALIGNANCIES, Blood, 84(10), 1994, pp. 10000336-10000336

Authors: BRODSKY I BIGGS JC SZER J CRILLEY P ATKINSON K DOWNS K DODDS A CONCANNON AJ AVALOS BR TUTSCHKA P KAPOOR N TOPOLSKY D BULOVA SI COPELAN EA
Citation: I. Brodsky et al., TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA WITH ALLOGENEIC BONE-MARROWTRANSPLANTATION AFTER PREPARATION WITH BUSULFAN AND CYCLOPHOSPHAMIDE (BUCY2) - AN UPDATE, Seminars in oncology, 20(4), 1993, pp. 27-31

Authors: CRILLEY P LAZARUS H TOPOLSKY D CIOBANU N CREGER RJ FOX RM BULOVA SI SHINA DC GUCALP R COOPER BW SOEGIARSO W STYLER M BRODSKY I
Citation: P. Crilley et al., COMPARISON OF PREPARATIVE TRANSPLANTATION REGIMENS USING CARMUSTINE ETOPOSIDE CISPLATIN OR BUSULFAN ETOPOSIDE CYCLOPHOSPHAMIDE IN LYMPHOID MALIGNANCIES, Seminars in oncology, 20(4), 1993, pp. 50-54

Authors: LINKER CA DAMON LE RIES CA RUGO HS WOLF JL CASE DC TOPOLSKY D BULOVA S CRILLEY P BRODSKY I
Citation: Ca. Linker et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOID-LEUKEMIA USING BUSULFAN ETOPOSIDE AS PREPARATIVE REGIMEN, Blood, 82(10), 1993, pp. 10000328-10000328

Authors: STYLER M BIGGS JC TOPOLSKY D ATKINSON K BULOVA S DOWNS K KOZUCH P BRODSKY I CRILLEY P
Citation: M. Styler et al., INCIDENCE OF VENOOCCLUSIVE DISEASE OF THE LIVER (VOD) AFTER MARROW CONDITIONING WITH BUSULFAN AND 2 DAYS OF CYCLOPHOSPHAMIDE (BUCY2), Blood, 82(10), 1993, pp. 10000642-10000642
Risultati: 1-19 |